Found: 62
Select item for more details and to access through your institution.
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 1, p. 1, doi. 10.1007/s10147-023-02430-x
- By:
- Publication type:
- Article
Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology‐based cross‐organ study.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 12, p. 1997, doi. 10.1002/ijc.34680
- By:
- Publication type:
- Article
Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers.
- Published in:
- Cancer Science, 2023, v. 114, n. 6, p. 2254, doi. 10.1111/cas.15776
- By:
- Publication type:
- Article
High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 10, p. 3498, doi. 10.1111/cas.15500
- By:
- Publication type:
- Article
Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1564, doi. 10.1111/cas.15313
- By:
- Publication type:
- Article
Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse.
- Published in:
- Cancer Science, 2022, v. 113, n. 4, p. 1113, doi. 10.1111/cas.15291
- By:
- Publication type:
- Article
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Greater extent of blood‐tumor TCR repertoire overlap is associated with favorable clinical responses to PD‐1 blockade.
- Published in:
- Cancer Science, 2021, v. 112, n. 8, p. 2993, doi. 10.1111/cas.14975
- By:
- Publication type:
- Article
Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 3, p. 546, doi. 10.1002/ijc.33545
- By:
- Publication type:
- Article
Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterations.
- Published in:
- Histopathology, 2021, v. 78, n. 7, p. 987, doi. 10.1111/his.14311
- By:
- Publication type:
- Article
Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer.
- Published in:
- Pathobiology, 2021, v. 88, n. 3, p. 218, doi. 10.1159/000511557
- By:
- Publication type:
- Article
Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcoma.
- Published in:
- Oncology Letters, 2021, v. 21, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12473
- By:
- Publication type:
- Article
Immunotherapy with 4-1BBL-Expressing iPS Cell‐Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1958, doi. 10.3390/ijms22041958
- By:
- Publication type:
- Article
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 550, doi. 10.3390/cancers13030550
- By:
- Publication type:
- Article
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20658-3
- By:
- Publication type:
- Article
Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
- Published in:
- Genome Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13059-020-02240-8
- By:
- Publication type:
- Article
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.564714
- By:
- Publication type:
- Article
Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 8, p. 2736, doi. 10.1111/cas.14451
- By:
- Publication type:
- Article
Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis.
- Published in:
- Cancer Science, 2020, v. 111, n. 8, p. 2747, doi. 10.1111/cas.14497
- By:
- Publication type:
- Article
Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innate lymphoid cells.
- Published in:
- Cancer Science, 2020, v. 111, n. 5, p. 1478, doi. 10.1111/cas.14374
- By:
- Publication type:
- Article
Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery.
- Published in:
- Oncology Letters, 2020, v. 19, n. 4, p. 2657, doi. 10.3892/ol.2020.11371
- By:
- Publication type:
- Article
Plasma and tumoral glypican‐3 levels are correlated in patients with hepatitis C virus‐related hepatocellular carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 2, p. 334, doi. 10.1111/cas.14251
- By:
- Publication type:
- Article
Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 1, p. 23, doi. 10.1111/cas.14223
- By:
- Publication type:
- Article
Efficacy of the NCCV Cocktail‐1 vaccine for refractory pediatric solid tumors: A phase I clinical trial.
- Published in:
- Cancer Science, 2019, v. 110, n. 12, p. 3650, doi. 10.1111/cas.14206
- By:
- Publication type:
- Article
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.
- Published in:
- Cancer Science, 2019, v. 110, n. 10, p. 3049, doi. 10.1111/cas.14165
- By:
- Publication type:
- Article
Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes.
- Published in:
- Cancer Science, 2019, v. 110, n. 6, p. 1842, doi. 10.1111/cas.14022
- By:
- Publication type:
- Article
Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-42392-7
- By:
- Publication type:
- Article
Next-Generation Cancer Immunotherapy Targeting Glypican-3.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00248
- By:
- Publication type:
- Article
Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-31383-9
- By:
- Publication type:
- Article
Cancer immunotherapy‐targeted glypican‐3 or neoantigens.
- Published in:
- Cancer Science, 2018, v. 109, n. 3, p. 531, doi. 10.1111/cas.13485
- By:
- Publication type:
- Article
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0191109
- By:
- Publication type:
- Article
A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0162394
- By:
- Publication type:
- Article
Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 5, p. 1794, doi. 10.3892/ijo.2016.3403
- By:
- Publication type:
- Article
Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
- Published in:
- Cancer Science, 2016, v. 107, n. 1, p. 95, doi. 10.1111/cas.12846
- By:
- Publication type:
- Article
Time-lapse imaging assay using the BioStation CT: A sensitive drug-screening method for three-dimensional cell culture.
- Published in:
- Cancer Science, 2015, v. 106, n. 6, p. 757, doi. 10.1111/cas.12667
- By:
- Publication type:
- Article
Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3.
- Published in:
- Clinical Case Reports, 2015, v. 3, n. 6, p. 444, doi. 10.1002/ccr3.279
- By:
- Publication type:
- Article
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
- Published in:
- Oncology Reports, 2015, v. 33, n. 4, p. 1837, doi. 10.3892/or.2015.3767
- By:
- Publication type:
- Article
A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 2, p. 497, doi. 10.3892/ijo.2014.2787
- By:
- Publication type:
- Article
Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 1, p. 28, doi. 10.3892/ijo.2014.2737
- By:
- Publication type:
- Article
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 5, p. 1847, doi. 10.3892/ijo.2014.2634
- By:
- Publication type:
- Article
Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus.
- Published in:
- Oncology Reports, 2014, v. 32, n. 5, p. 1772, doi. 10.3892/or.2014.3436
- By:
- Publication type:
- Article
Identification of a novel HLA-A*02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.
- Published in:
- Oncology Reports, 2014, v. 32, n. 1, p. 33, doi. 10.3892/or.2014.3198
- By:
- Publication type:
- Article
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084807
- By:
- Publication type:
- Article
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 639, doi. 10.1007/s00262-012-1366-6
- By:
- Publication type:
- Article
Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.
- Published in:
- Cancer Science, 2011, v. 102, n. 9, p. 1622, doi. 10.1111/j.1349-7006.2011.02003.x
- By:
- Publication type:
- Article
HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells.
- Published in:
- Cancer Science, 2011, v. 102, n. 5, p. 918, doi. 10.1111/j.1349-7006.2011.01896.x
- By:
- Publication type:
- Article
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 9, p. 2153, doi. 10.1002/ijc.24836
- By:
- Publication type:
- Article